Morgan Stanley analyst Michael Cyprys raised the firm’s price target on Brookfield Corp. (BN) to $61 from $60 and keeps an Overweight rating on the shares. Into Q1 results, the firm lowered EPS estimates 9% on average and is 1% ahead of consensus on a median basis across its alternative asset manager coverage, the analyst tells investors in a preview for the group.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BN:
- Brookfield Corporation Prices C$750 Million Canadian Medium-Term Note Offering
- Brookfield Sets Date for First-Quarter 2026 Results Call
- Sumitomo, SMBC, Apollo and Brookfield completes Air Lease acquisition
- Brookfield Corp. price target lowered to $48.50 from $52 at Scotiabank
- Brookfield Files 2025 Annual Report With U.S. and Canadian Regulators